Plus Therapeutics, Inc.

NasdaqCM:PSTV Stok Raporu

Piyasa değeri: US$8.0m

Plus Therapeutics Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 0/6

Plus Therapeutics has a total shareholder equity of $-7.6M and total debt of $3.3M, which brings its debt-to-equity ratio to -43.2%. Its total assets and total liabilities are $11.2M and $18.8M respectively.

Anahtar bilgiler

-43.2%

Borç/özkaynak oranı

US$3.29m

Borç

Faiz karşılama oranın/a
NakitUS$8.44m
Eşitlik-US$7.62m
Toplam yükümlülüklerUS$18.84m
Toplam varlıklarUS$11.21m

Son finansal sağlık güncellemeleri

Recent updates

Plus Therapeutics jumps 18% as JonesTrading adds another Buy rating

Oct 07

Plus Therapeutics finalizes $17.6M grant from Texas, to get initial funds by October end

Sep 22

Plus Therapeutics GAAP EPS of -$0.24 misses by $0.02

Jul 21

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: PSTV has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Uzun Vadeli Yükümlülükler: PSTV has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: PSTV has negative shareholder equity, which is a more serious situation than a high debt level.

Borcun Azaltılması: PSTV's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Bilanço


Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: PSTV has less than a year of cash runway based on its current free cash flow.

Tahmini Nakit Akışı: PSTV has less than a year of cash runway if free cash flow continues to reduce at historical rates of 5.1% each year


Sağlıklı şirketleri keşfedin